List view / Grid view
2 July 2014 | By Pfizer
Pfizer Inc. announced that the Orthodox Union has granted kosher certification to ELELYSO™ (taliglucerase alfa) for injection, an enzyme replacement therapy for the long-term treatment of adults with a confirmed diagnosis of Type 1 Gaucher disease...
2 July 2014 | By Boehringer Ingelheim
Boehringer Ingelheim announced submission of Marketing Authorisation Applications in 31 European countries for the once-daily fixed-dose combination of tiotropium + olodaterol in the Respimat® Soft Mist™ Inhaler...
2 July 2014 | By Roche
Acquisition of Phase I program offers a potential new approach for hormone receptor-positive breast cancer...
2 July 2014 | By Actavis
Actavis plc announced the appointment of three new members to the Company's Board of Directors, including Actavis' newly appointed CEO and President, Brenton L. Saunders...
2 July 2014 | By Daiichi Sankyo
Daiichi Sankyo Company, Limited announced that its affiliated foundation, the Daiichi Sankyo Foundation of Life Science has awarded its 12th Takamine Memorial Daiichi Sankyo Prize...
1 July 2014 | By kdm communications
Cresset, innovative provider of computational chemistry software and services, announces the release of Torch V10.3...
1 July 2014 | By GlaxoSmithKline
GlaxoSmithKline plc and Theravance, Inc. announced the submission of a supplemental New Drug Application to the US Food and Drug Administration for a fixed dose combination of the inhaled corticosteroid, fluticasone furoate and the long-acting beta2 agonist, vilanterol...
1 July 2014 | By The European Medicines Agency
The European Medicines Agency’s Committee for Advanced Therapies has revised a reflection paper on the classification of advanced-therapy medicinal products to reflect the current thinking of the committee on how ATMPs should be classified...
1 July 2014 | By Johnson & Johnson
Johnson & Johnson announced that it has completed the divestiture of its Ortho-Clinical Diagnostics business to The Carlyle Group for approximately $4 billion...
1 July 2014 | By Merck
Merck planning regulatory submissions in the U.S. for EMEND® in pediatric setting including new suspension formulation in second half of 2014...
30 June 2014 | By Roche
Roche announced the launch of cobas® 6500, a fully automated urine testing system that consists of two modular analyzers combining urine strip testing and digital urinary microscopy...
30 June 2014 | By Novartis
Sandoz announces a long-term commitment to help prevent the deaths of millions of children worldwide by supplying a key antibiotic formulation...
30 June 2014 | By Boehringer Ingelheim
The U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to the investigational antidote idarucizumab...
30 June 2014 | By GlaxoSmithKline
GSK and Save the Children announced the launch of their second annual $1 million Healthcare Innovation Award at the Partnership for Maternal, Newborn and Child Health meeting in South Africa...
30 June 2014 | By Merck
Merck announced the European Medicines Agency has accepted for review a Marketing Authorization Application for pembrolizumab (MK-3475)...
